Stingray Healthcare Group, the UK’s largest private oncology provider operating in eight countries, has acquired the Centre de Cancérologie de la Porte de Saint-Cloud (CCPSC), a radiotherapy and oncology centre in Paris, France through its French subsidiary Amethyst.



